Characteristics of Heart Failure Patients based on Its Causes in Camelia Hospitalization Room Dr. Soetomo General Hospital Surabaya January - December 2017
Downloads
Introduction: Heart failure is one of cardiovascular diseases which becomes a global health problem, especially in Indonesia. It's a clinical syndrome caused by variety of underlying diseases. Different causes that cause heart failure in patients will certainly lead to different manifestations and outcomes.
Methods: This research was a descriptive study using secondary data taken from the patient's medical records. The number of samples in this study were 197 patients with heart failure in Camelia Hospitalization Room Dr. Soetomo General Hospital Surabaya. Sampling technique was total sampling. The variables were age, sex, stage, symptoms, physical examination, and pharmacological treatment. The data were analyzed descriptively.
Results: Most heart failure causes in this hospital was coronary heart disease (40.6%). Patients aged 46-65 years old and male patients were more dominant although the difference was not really significant. Male patients were dominant in heart failure due to coronary heart disease and hypertension, meanwhile female patients were dominant in heart valve disease and other causes. Most patients in all causes of heart failure were diagnosed at advanced stage, such as stage III (35.5%) and stage IV (35.5%). Main symptom that was found more in the patients was dyspnea (70.1%), which could be found in coronary & heart valve disease. Physical examination results were based on the causes. Most pharmacological treatments that the patients had were Furosemide (88.3%) and Spironolactone (73.6%).
Conclusion: Coronary heart disease still becomes the main cause of heart failure. Heart failure was more common in early and late elderly (46-65 years old), with male patients were more dominant. More patients were diagnosed at advanced stage. Symptom that was found more was dyspnea. Physical examination results were various based on its causes. Pharmacological treatments that the patients had gotten were Furosemide, kind of diuretics, and Spironolactone, kind of aldosterone antagonist.
Thibodeau D. Heart Failure. Physician Assistant Clinics. 2017; 2: 651-70.
Bui AL, Horwich TB and Fonarow GC. Epidemiology and Risk Profile of Heart Failure. Nat Rev Cardiol. 2011; 8: 30-41.
Indonesia PDDIKKR. Situasi Kesehatan Jantung. Jakarta: Kementerian Kesehatan Republik Indonesia, 2013.
Mcmurray JJ and Stewart S. Epidemiology, Aetiology, and Prognosis of Heart Failure. Heart. 2000; 83: 596-602.
Kajimoto K, Minami Y, Sato N and Kasanuki H. Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure with Preserved or Reduced Ejection Fraction. Am J Cardiol. 2016; 118: 1881-7.
The Relationship of LV Ejection Fraction and Nyha Classification in Congestive Heart Failure Patients. Europace. 2005; 7: 88-9.
Indonesia PDSK. Pedoman Tata Laksanan Gagal Jantung. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia, 2015.
Lala A and Desai AS. The Role of Coronary Artery Disease in Heart Failure. Heart Failure Clinics. 2014; 10: 353-65.
Dharmarajan K and Rich MW. Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults. Heart Failure Clinics. 2017; 13: 417-26.
Syukri AEDP. Profil Penyakit Jantung Koroner di Irina F Jantung RSUP Prof. Dr. R. D. Kandou Manado. Jurnal E-Clinic (Ecl). 2013; 1.
Rosano G. Valvular Heart Disease in Heart Failure. 2017. 2017; 10.
Lilly L. Pathophysiology of Heart Disease. Philadelphia: Lippincott Williams & Wilkins, 2011.
Trevisan L, Cautela J, Resseguier N, et al. Prevalence and Characteristics of Coronary Artery Disease in Heart Failure with Preserved and Mid-Range Ejection Fractions: A Systematic Angiography Approach. Archives of Cardiovascular Diseases. 2018; 111: 109-18.
Frigerio M and Roubina E. Drugs for Left Ventricular Remodeling in Heart Failure. The American Journal of Cardiology. 2005; 96: 10-8.
Tambuwun CF, Panda AL and Rampengan SH. Gambaran Pasien Gagal Jantung dengan Penyakit Hipertensi yang Menjalani Rawat Inap di RSUP Prof. Dr. R. D. Kandou Manado Periode September – November 2016. Jurnal E-Clinic (ECL). 2016; 4.
Copyright (c) 2020 Chronica Elsa Retta Lumban Tobing, Budi Baktijasa Dharmadjati, Heroe Soebroto
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).